(Q34137993)

31 July 2017

title

Developing non-viral DNA delivery systems for cancer and infectious disease (English)

1 reference

31 July 2017

E G. Spack

1

1 reference

31 July 2017

F L. Sorgi

series ordinal

2

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

6

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

186-197

1 reference

Gene therapy -- promises, problems and prospects

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Adenovirus vectors for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Direct gene transfer into mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

The role of CpG motifs in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Advantages of non-human adenoviruses versus human adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Towards gene therapy for cystic fibrosis: a clinical progress report.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Liposomal gene delivery: a complex package

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Liposome-mediated, nonviral gene transfer induces a systemic inflammatory response which can exacerbate pre-existing inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Toxicity of cationic liposome-DNA complex in lung isografts

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Genetic immunization is a simple method for eliciting an immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Conjugation of protein to immunostimulatory DNA results in a rapid, long-lasting and potent induction of cell-mediated and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Uses of granulocyte-macrophage colony-stimulating factor in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Potentiation of cationic liposome-mediated gene delivery by polycations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Protamine sulfate enhances lipid-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Use of plasmid DNA for direct gene transfer and immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Electropermeabilization of skeletal muscle enhances gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA-based immunization by in vivo transfection of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA and RNA-based vaccines: principles, progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

A novel method for DEAE-dextran mediated transfection of adherent primary cultured human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Receptor-mediated gene transfer into macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Enhancing DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccines for viral diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

1 reference

7 January 2021

The prime-boost strategy: exciting prospects for improved vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

DNA vaccines against cancer: from genes to therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Colorectal cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: a phase I/II clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2800%2901633-0

7 January 2021

10.1016/S1359-6446(00)01633-0

Identifiers

DOI

1 reference

31 July 2017

1 reference